TRPV1 activation in microglia exacerbates ICH injury by promoting inflammation and disruptive mitophagy. Targeted inhibition of microglial TRPV1 represents a promising therapeutic strategy for ICH.
Share your take
Add a clinician perspective alongside expert commentary.
Chen et al. (Wed,) studied this question.